Studies with ethyl chlorophenoxyisobutyrate (clofibrate)
Authors:
- Daniel L. AzarnoffDADaniel L. Azarnoff
- Donald R. TuckerDTDonald R. Tucker
- Glenn A. BarrGBGlenn A. Barr
- 1 September 1965
- journal article
- research article
- Published by Elsevier in Metabolism
- Vol. 14 (9) , 959-965
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Reduction of Cholesterol and Lipids in Man by Ethyl p-ChlorophenoxyisobutyrateAnnals of Internal Medicine, 1963
- Experimental studies of the toxicity of atromid with particular reference to fine structural changes in the livers of rodentsJournal of Atherosclerosis Research, 1963
- The effect of atromid on arterial disease induced by semi-synthetic diet in the rabbitJournal of Atherosclerosis Research, 1963
- Further observations on the effects of atromid and of ethyl chlorophenoxyisobutyrate on serum lipid levelsJournal of Atherosclerosis Research, 1963
- EXPERIMENTAL EVALUATION OF AN ORALLY ACTIVE COMBINATION OF ANDROSTERONE WITH ETHYL CHLOROPHENOXYISOBUTYRATEThe Lancet, 1962
- Modification of Metabolism and Distribution of Lipids by Ethyl ChlorophenoxyisobutyrateNature, 1962
- REDUCTION OF SERUM-LIPID AND URIC-ACID LEVELS BY AN ORALLY ACTIVE ANDROSTERONEThe Lancet, 1962
- Determination of 3-β-OH sterols in serum and tissues by the anthrone reactionArchives of Biochemistry and Biophysics, 1959
- Inhibition of Cholesterol Biosynthesis in ManArchives of internal medicine (1960), 1958
- THE DOMINANT ROLE OF THE LIVER IN PLASMA PROTEIN SYNTHESISJournal of Experimental Medicine, 1951